BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4465036)

  • 1. [Immunologic study of a case of spontaneous regression of metastatic carcinoma of the portio].
    Moggian G; Barboni F; Sabetta C
    Cancro; 1974; 27(3):165-8. PubMed ID: 4465036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS; Giraudo Conesa LC; Chevallier R
    Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic squamous cell carcinoma of the cervix. The role of immunology in its pathogenesis.
    Davidsohn I; Norris HJ; Stejskal R; Lill P
    Arch Pathol; 1973 Feb; 95(2):132-4. PubMed ID: 4683161
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic reaction of cervical lymph nodes in relation to metastasis and prognosis of oral squamous cell carcinoma (author's transl)].
    Yan LJ
    Zhonghua Kou Qiang Ke Za Zhi; 1980 Mar; 15(1):5-7. PubMed ID: 6950890
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of colony formation by cytotoxic antibodies in cervical epidermoid carcinoma.
    Byfield JE; Weintraub I; Klisak I; Lagasse LD
    Radiology; 1973 Jun; 107(3):685-6. PubMed ID: 4735695
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isolation of tumour localizing antibodies by immunosorbents. 3. Isolation of heterologous antibodies against human portio carcinoma and hypernephroma (author's transl)].
    Teichmann B; Vogt R
    Arch Geschwulstforsch; 1974; 43(2):145-56. PubMed ID: 4849017
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
    Chiang WT; Wei PY; Alexander ER
    Am J Obstet Gynecol; 1976 Sep; 126(1):116-21. PubMed ID: 786019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.
    DiSaia PJ; Sinkovics JG; Rutledge FN; Smith JP
    Am J Obstet Gynecol; 1972 Dec; 114(7):979-89. PubMed ID: 4118903
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
    Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological status in cervical cancer in relation to pelvic irradiation.
    Chandra M; Chander S
    Indian J Med Res; 1986 Oct; 84():413-7. PubMed ID: 3781598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stimulation of a built-in body defence mechanism against carcinoma of the cervix: a clinical experimental study (author's transl)].
    Michalica W
    Wien Klin Wochenschr Suppl; 1974; 29():1-30. PubMed ID: 4530548
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
    Nedergaard BS; Ladekarl M; Nyengaard JR; Nielsen K
    Gynecol Oncol; 2008 Jan; 108(1):106-11. PubMed ID: 17945335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of humoral antibody responses in patients with carcinoma of the cervix.
    Vos GH; Hammond MG; Vos D; Grobbelaar BG; Auslander HP; Marescotti G
    J Obstet Gynaecol Br Commonw; 1972 Nov; 79(11):1040-6. PubMed ID: 4642378
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 20. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.